ArticleVascular health and risk management2026
The Association of Remnant Cholesterol with Obstructive Sleep Apnea and Coronary Heart Disease: A Cross-Sectional Study.
Article in Vascular health and risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea (OSA) is a significant risk factor for coronary heart disease (CHD), yet the precise pathophysiological mechanisms linking them remain incompletely understood. Remnant cholesterol (RC), as an atherogenic lipoprotein, is considered a key driver of residual cardiovascular risk. However, evidence regarding the role of RC in the association between OSA and CHD is still lacking. Methods: In this single-center, cross-sectional study, we enrolled 368 consecutive patients with suspected coronary heart disease (CHD). All participants underwent overnight polysomnography (PSG) and were categorized into none/mild or moderate/severe obstructive sleep apnea (OSA) groups based on the apnea-hypopnea index (AHI). Coronary artery disease was assessed via angiography or computed tomography angiography (CTA), and its severity was quantified by the number of diseased vessels. Results: Compared to the none/mild OSA group, patients with moderate/severe OSA had a significantly higher prevalence of CHD (73.0% vs. 15.2%, p<0.001) and a greater proportion of multi-vessel disease (p<0.001). AHI was strongly positively correlated with the number of diseased vessels (overall population r=0.612, p<0.001). Multiple Linear Regression identified AHI as an independent determinant of the number of diseased vessels (β=0.804, p<0.001). Logistic regression confirmed that the number of diseased vessels was an independent risk factor for moderate/severe OSA (OR=3.575, p<0.001). While remnant cholesterol was not significantly correlated with AHI in the overall population (r=-0.051, p=0.327), it showed weak negative correlations with the number of diseased vessels in males (r=-0.120, p=0.036) and in the moderate/severe OSA subgroup (r=-0.130, p=0.035), which may be influenced by residual confounding factors. Conclusion: This study demonstrates a strong and significant independent association between OSA severity and the presence and severity of CHD. Although remnant cholesterol showed no global association with OSA severity, its weak inverse correlation with coronary disease in males and severe OSA patients suggests a potential complex role, warranting further investigation into its mechanisms within specific populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.